Dual Neuromodulation Remodels Neuro-Immune Crosstalk and Chemokine Network for Combating Postoperative Progression of Prostate Cancer.
The autonomic nerves drive prostate cancer (PCa) progression, yet a strategy for dual modulation of sympathetic and parasympathetic nerves remains undeveloped. Here, building on the multicenter clinical findings, we develop a personalized nanotechnology-enabled dual neurotherapy (denoted as ADNT) for PCa....
🗓️ 2026-10-29
📰 Publication: Advanced Materials
Read MoreDual Neuromodulation Remodels Neuro-Immune Crosstalk and Chemokine Network for Combating Postoperative Progression of Prostate Cancer.